Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Einzigartiges Zentrum
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (10)
2024
-
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Vaccines, Vol. 12, Núm. 1
-
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)
npj Vaccines
-
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Emerging Microbes and Infections, Vol. 13, Núm. 1
-
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines, Vol. 9, Núm. 1
-
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
A tetracationic porphyrin with dual anti-prion activity
iScience, Vol. 26, Núm. 9
-
Understanding the key features of the spontaneous formation of bona fide prions through a novel methodology that enables their swift and consistent generation
Acta Neuropathologica Communications, Vol. 11, Núm. 1
2022
-
Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model
Acta Neuropathologica Communications, Vol. 10, Núm. 1
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806